Header Logo

Connection

WILLIAM WONG to Quinolines

Back to Details
This is a "connection" page, showing publications WILLIAM WONG has written about Quinolines.
WILLIAM WONG
Connection Strength
0.152
Quinolines
  1. Lenvatinib Versus Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost-Utility Analysis. Oncologist. 2020 03; 25(3):e512-e519.
    View in: PubMed
    Score: 0.152
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.